Beijing Bohui Innovation Technology Co., Ltd.
300318 · SZSE · China
bohui-tech.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- PositionCurrent ratio is 0.88×, lower than 95% of its Biotechnology peers (median 5.6×)
- FinancialsAltman Z-Score 1.07: distress zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.21BCNY586.51M · vs all stocks (USD)
Revenue (TTM)
821.94MCNY122.33M · vs all stocks (USD)
Profit Margin
-10.09%vs Biotechnology peers
Beta
0.2920xvs all stocks
52-Week Change
-40.63%vs all stocks
Market Capitalization
3.21BCNY586.51M · vs all stocks (USD)
Enterprise Value
4.84BCNY835.07M · vs all stocks (USD)
Price to Sales (TTM)
3.91xvs Biotechnology peers
Price to Book (MRQ)
2.54xvs Biotechnology peers
Enterprise to Revenue
5.89xvs Biotechnology peers
Enterprise to EBITDA
278.39xvs Biotechnology peers
Gross Margin
35.61%vs Biotechnology peers
Profit Margin
-10.09%vs Biotechnology peers
Operating Margin
-8.01%vs Biotechnology peers
Return on Assets (TTM)
-0.94%vs Biotechnology peers
Return on Equity (TTM)
-7.16%vs Biotechnology peers
Revenue (TTM)
821.94MCNY122.33M · vs all stocks (USD)
Revenue per Share (TTM)
1.01CNYUpdated Nov 22, 2026Quarterly Revenue Growth
2.60%vs Biotechnology peers
Gross Profit (TTM)
251.11MCNY39.01M · vs all stocks (USD)
EBITDA (TTM)
51.19MCNY7.67M · vs all stocks (USD)
Net Income (TTM)
-82.94MCNY-13.32M · vs all stocks (USD)
Operating Cash Flow (TTM)
-99.76MCNY-18.17M · vs all stocks (USD)
5-Year Average Dividend Yield
0.05%vs all stocks
Payout Ratio
0.00%vs Biotechnology peers
Minority Interest (Equity)
890.81MCNYFY2025 · Dec 31, 2025Revenue
824.58MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
498.40MCNYFY2025 · Dec 31, 2025Gross Profit
326.17MCNYFY2025 · Dec 31, 2025Operating Income
6.95MCNY1.04M · vs all stocks (USD)
Pre-tax Income
-171.31MCNYFY2025 · Dec 31, 2025Income Tax Expense
694.86KCNYFY2025 · Dec 31, 2025Net Income
-172.01MCNYFY2025 · Dec 31, 2025EBIT
-137.89MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
51.19MCNYFY2025 · Dec 31, 2025Research & Development
64.92MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
82.62MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
33.43MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1125CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1125CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
817.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
817.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-172.01MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
80.08MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-347.79MCNYFY2025 · Dec 31, 2025Free Cash Flow
-474.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
103.33MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-172.01MCNYFY2025 · Dec 31, 2025Other Non-cash Items
46.41MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-52.78MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-169.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-126.63MCNYFY2025 · Dec 31, 2025Purchase of Investments
-15.95MCNYFY2025 · Dec 31, 2025Sale of Investments
17.13MCNYFY2025 · Dec 31, 2025Other Investing Activity
46.41KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-125.41MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.00BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-921.24MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-31.38MCNYFY2025 · Dec 31, 2025Other Financing Charges
257.63MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
308.21MCNYFY2025 · Dec 31, 2025Shares Outstanding
816.90MSharesUpdated Nov 22, 2026Float Shares
327.45MSharesUpdated Nov 22, 2026% Held by Insiders
60.68%vs all stocks
% Held by Institutions
0.50%vs all stocks
Total Cash (MRQ)
135.95MCNY20.13M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1660CNYUpdated Nov 22, 2026Total Debt (MRQ)
902.45MCNY138.45M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4234xvs Biotechnology peers
Current Ratio (MRQ)
0.8820xvs Biotechnology peers
Book Value per Share (MRQ)
1.55CNYUpdated Nov 22, 2026Total Assets
4.30BCNY645.16M · vs all stocks (USD)
Total Current Assets
1.43BCNYFY2025 · Dec 31, 2025Total Liabilities
2.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.88BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
597.48MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.53BCNYFY2025 · Dec 31, 2025Cash
101.11MCNYFY2025 · Dec 31, 2025Cash Equivalents
20.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
121.83MCNYFY2025 · Dec 31, 2025Accounts Receivable
89.75MCNYFY2025 · Dec 31, 2025Inventory
1.14BCNYFY2025 · Dec 31, 2025Accounts Payable
220.40MCNYFY2025 · Dec 31, 2025Short-term Debt
654.81MCNYFY2025 · Dec 31, 2025Other Current Liabilities
5.13MCNYFY2025 · Dec 31, 2025Long-term Debt
471.94MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
816.90MCNYFY2025 · Dec 31, 2025Retained Earnings
-291.21MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.18BCNY326.16M · vs all stocks (USD)
52-Week Low
3.92CNYUpdated Nov 22, 202652-Week High
8.17CNYUpdated Nov 22, 202652-Week Change
-40.63%vs all stocks
Beta
0.2920xvs all stocks
50-Day MA
4.81CNYUpdated Nov 22, 2026200-Day MA
5.19CNYUpdated Nov 22, 2026Avg 10-Day Volume
5.65MSharesUpdated Nov 22, 2026Avg 30-Day Volume
6.65MSharesUpdated Nov 22, 2026Diluted EPS (TTM)
-0.1000CNYUpdated Nov 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.88×, lower than 95% of its Biotechnology peers (median 5.6×)Significant
Current ratio: 0.88Industry median: 5.60Industry P5: 1.03Peers compared: 245
Financial Health
Altman Z-Score 1.07: distress zoneCritical
Altman Z-Score: 1.07
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hvsen Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ironwood Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sinotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Candel Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule